Search clinical trials for: Secretory Leukocyte Peptidase Inhibitor
Total 1171 results
-
LMC Diabetes & Endocrinology Ltd.Merck Sharp & Dohme LLC; Syreon CorporationWithdrawnType2 Diabetes
-
Oslo University HospitalVestre Viken Hospital Trust; University of Oslo; The Research Council of Norway; University Hospital, Akershus and other collaboratorsRecruitingGlucose Metabolism Disorders | Impaired Glucose Tolerance | Insulin SensitivityNorway
-
Brigham and Women's HospitalCompletedDiabetes MellitusUnited States
-
Brigham and Women's HospitalCompleted
-
SanofiCompletedDiabetes Mellitus, Type 2Korea, Republic of
-
Mitsui Memorial HospitalMitsukoshi Health and Welfare FoundationCompletedHeart Failure | Diabetes MellitusJapan
-
SINA Health Education and Welfare TrustHorizon Pharmaceutical Pvt LtdCompletedGlucose Metabolism Disorders | Diabetes Mellitus, Type 2 | Hypoglycemic Agents | EmpagliflozinPakistan
-
Phoenix VA Health Care SystemBristol-Myers SquibbCompletedType 2 Diabetes Mellitus (T2DM)United States
-
dr. DJ MulderBoehringer IngelheimCompletedType 2 Diabetes MellitusNetherlands
-
JW PharmaceuticalActive, not recruitingType 2 Diabetes MellitusKorea, Republic of
-
NovartisCompletedDiabetes Mellitus, Type 2Germany
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2United States
-
NovartisCompleted
-
NovartisCompletedDiabetes Mellitus, Type 2Japan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Poland, Slovakia, Canada, Slovenia, Greece, Czechia
-
Novartis PharmaceuticalsCompletedDiabetes | Renal ImpairmentRussian Federation
-
NovartisCompletedDiabetes Mellitus, Type 2Japan
-
NovartisCompletedDiabetes Mellitus, Type 2Japan
-
NovartisCompleted
-
University of BergenUnknown
-
MTI UniversityNational Institute of Diabetes and Endocrinology, EgyptRecruitingType 2 Diabetes MellitusEgypt
-
University Malaysia SarawakSarawak General HospitalCompleted
-
NovartisCompletedDiabetes Mellitus, Type 2United States, Germany
-
Medical University of ViennaCompleted
-
Mayo ClinicRecruiting
-
NovartisCompleted
-
NovartisCompletedDiabetes Mellitus, Type 2United States, Germany
-
Novartis PharmaceuticalsCompletedType 2 Diabetes MellitusUnited Kingdom, Belgium, Bulgaria, Spain, Slovakia, Germany, Finland
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2United States
-
Boehringer IngelheimEli Lilly and CompanyActive, not recruiting
-
Nanjing Medical UniversityUnknown
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2United States
-
NovartisCompletedDiabetes Mellitus, Type 2Germany, United States
-
NovartisCompletedDiabetes Mellitus, Type 2
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Switzerland
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2United States, Germany
-
NovartisCompletedType 2 Diabetes MellitusGermany, Romania, Hungary, Belgium, Slovakia, Australia, India, Czech Republic, Guatemala, Hong Kong, United Kingdom
-
NovartisCompletedVildagliptin Compared to Pioglitazone in Combination With Metformin in Patients With Type 2 DiabetesDiabetes Mellitus, Type 2United States, Germany
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Germany
-
Novartis PharmaceuticalsCompletedEfficacy and Safety of Vildagliptin Compared to Acarbose in Drug Naive Patients With Type 2 DiabetesDiabetes Mellitus, Type 2Switzerland
-
NovartisCompletedPrediabetic StateUnited States
-
NovartisCompletedType 2 Diabetes MellitusGermany
-
NovartisCompletedDiabetes Mellitus, Type 2United States, Philippines, India, Puerto Rico, Canada, Malaysia, Romania, Slovakia
-
India Diabetes Research Foundation & Dr. A. Ramachandran...CompletedTYpe 2 Diabetes MellitusIndia
-
NovartisCompletedDiabetes Mellitus, Type 2United States
-
Royal Devon and Exeter NHS Foundation TrustNovartis Pharmaceuticals; National Institute for Health Research, United KingdomCompletedInsulin Resistance | Microvascular DiseaseUnited Kingdom
-
NovartisCompletedDiabetes Mellitus, Type 2United States